Related Experiment Video
Updated: Aug 6, 2026

07:59
Ultra-Fast Amplicon-Based Next-Generation Sequencing in Non-Squamous Non-Small Cell Lung Cancer
Published on: September 8, 2023
Multi-task deep learning model for predicting EGFR mutation status in NSCLC
Qilong Song1,2,3, Xiaohu Li1, Biao Song1,2
1Department of Radiology, the First Affiliated Hospital of Anhui Medical University, Hefei, China.
NPJ Digital Medicine
|July 20, 2026
Summary
A novel multi-task deep learning model accurately predicts Epidermal growth factor receptor (EGFR) mutation status from CT scans for non-small cell lung cancer (NSCLC) patients, aiding personalized treatment decisions.
Area of Science:
- Oncology
- Radiology
- Artificial Intelligence
Background:
- Epidermal growth factor receptor (EGFR) mutation status is crucial for non-small cell lung cancer (NSCLC) treatment selection.
- Current methods for determining EGFR mutation status can be invasive.
- Deep learning (DL) offers potential for non-invasive predictive biomarkers.
Purpose of the Study:
- To develop and evaluate a multi-task deep learning (MTDL) model for predicting EGFR mutation status using CT images.
- To assess the association of the MTDL model's predictions with patient survival and tumor characteristics.
Main Methods:
- A multi-task deep learning (MTDL) model was developed to analyze CT images.
- The model was trained to predict EGFR mutation status.
- Performance was evaluated, and associations with survival and tumor microenvironment were analyzed.
Main Results:
- The MTDL model demonstrated promising accuracy in predicting EGFR mutation status.
- The MTDL score showed significant association with survival in patients undergoing EGFR-targeted therapy.
- The score also correlated with gene expression patterns and tumor microenvironment characteristics.
Conclusions:
- The developed MTDL model shows potential as an accurate, non-invasive biomarker for EGFR mutation status prediction in NSCLC.
- This approach can aid in personalized treatment strategies for NSCLC patients.
- Further validation is warranted to integrate this method into clinical practice.